Small
Bone Innovations has a Humanitarian Device Exemption (HDE) from
the FDA to market or SR™MCP and SR™PIP Finger Joint
Implants as Humanitarian Use Devices (HUD). An HUD is a device that
is intended to benefit patients by treating a disease or condition
that affects fewer than 4,000 individuals in the United States per
year. SBi acquired this HDE with the acquisition of Avanta Orthopaedics.
A Humanitarian Use Device (HUD) is a legally marketed device. However,
an HUD may only be used in facilities that have established a local
institutional review board (IRB) and after an IRB has approved the
use of the device to treat or diagnose the specific disease.
IRB approval must be obtained prior to SBi distributing this product
to a physician. We must receive a copy of a letter from the IRB
at the institution where the surgeon intends to perform surgeries
granting approval for the physician to use this Humanitarian Use
Device.
A simple letter from the local IRB to the treating physician approving
the use of the device should at a minimum contain the following
information:
1. Hospital name, address, telephone number;
2. Doctor's name and address
3. A statement that the IRB has reviewed and is approving the use
of the Proximal Interphalangeal Joint (H980002) or Metacarpophalangeal
Joint (H010001) for the approved indications;
4. Signature of the IRB chairperson.
Humanitatian Device Exemption Information –
http://www.fda.gov/cdrh/ode/hdeinfo.html
H980002, 28-Sep-98 Avanta Proximal Interphalangeal (PIP) Finger
Prosthesis,
H010001 28-Aug-01 Avanta Metacarpophalangeal (MCP) Finger Prosthesis.
HDE Regulation Questions and Answers
http://www.fda.gov/cdrh/ode/hdeqna.html
To request an HDE packet or if you have any questions regarding
getting IRB approval to use these implants, please contact SBi Customer
Service at 800.778.8837
|